INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID-19 (INHALE-HEP): Protocol and statistical analysis plan for an investigator-initiated international metatrial of randomised studies

Citation

van Haren PhD, F, Richardson, A, Yoon, H et al. 2020, 'INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID-19 (INHALE-HEP): Protocol and statistical analysis plan for an investigator-initiated international metatrial of randomised studies', British Journal of Clinical Pharmacology.

Year

2020

Fields of Research

  • Respiratory Diseases
  • Infectious Diseases

Updated:  31 July 2021 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers